This article is more than 5 years old. Information may no longer be current.

AGTC earns Innovator Award at OIS

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

CHICAGO — Applied Genetic Technologies Corp. was awarded with the Innovator Award here at the Ophthalmology Innovation Summit, ahead of the American Academy of Ophthalmology annual meeting.

The clinical-stage biotechnology company has developed adeno-associated virus-based gene therapies for X-linked retinoschisis, achromatopsia and X-linked retinitis pigmentosa.

Susan Washer, president and CEO of AGTC, and William W. Hauswirth, PhD, co-founder, were presented with the award. Nicholas Muzyczka, PhD, co-founder, also awarded, was not in attendance.